Video

The Future of CRISPR-Engineered Stem Cell Therapies: 3 Clinical Trial Examples

Source: Cell & Gene

The introduction of the CRISPR technology and the ability to grow stem cells in the lab have been among the most important breakthroughs in the scientific world. CRISPR-engineered stem cell therapies have made tremendous advancements in the past 5 years, but challenges still exist. From understanding that CRISPR is in fact safe if used in the appropriate context to learning how CRISPR affords potential for immediate patient impact, there is no need to question the permanency of gene editing. 

To learn more about CRISPR gene editing, Cell and Gene Chief Editor, Erin Harris, sat down with Sadik Kassim, Chief Technical Officer at Vor Biopharma to discuss the benefits of CRISPR-engineered stem cell therapies, the challenges and feasible solutions, what’s next, and more. 

VIEW THE VIDEO!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene